PROFOUND MEDICAL CORP. Increase (Decrease) in Accounts and Other Receivables
PROFOUND MEDICAL CORP. (PROF) reported Increase (Decrease) in Accounts and Other Receivables of $2.47 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2026-08-06
- PROFOUND MEDICAL CORP. increase (decrease) in accounts and other receivables for the quarter ending 2026-06-30 was $233.00K.
- PROFOUND MEDICAL CORP. increase (decrease) in accounts and other receivables for the quarter ending 2026-03-31 was $2.24M.
- PROFOUND MEDICAL CORP. increase (decrease) in accounts and other receivables for the quarter ending 2025-12-31 was -$736.00K, a 223.70% decline year-over-year.
- PROFOUND MEDICAL CORP. increase (decrease) in accounts and other receivables for the quarter ending 2025-09-30 was $3.36M.
- PROFOUND MEDICAL CORP. increase (decrease) in accounts and other receivables for fiscal 2025 was $172.00K.
- PROFOUND MEDICAL CORP. increase (decrease) in accounts and other receivables for fiscal 2024 was -$186.00K, a 119.46% decline from fiscal 2023.
- PROFOUND MEDICAL CORP. increase (decrease) in accounts and other receivables for fiscal 2023 was $956.00K.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 12 month |
|---|---|---|---|---|
| 2026-06-30 | $233.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.47M 10-Q · filed 2026-08-06 | $1.74M derived: sum of 3 quarters · filed 2026-08-06 | $5.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.24M 10-Q · filed 2026-05-07 | $1.50M derived: sum of 2 quarters · filed 2026-05-07 | $4.86M derived: sum of 3 quarters · filed 2026-05-07 | $3.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$736.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.62M derived: sum of 2 quarters · filed 2026-03-05 | $1.26M derived: sum of 3 quarters · filed 2026-08-06 | $172.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $3.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.00M derived: sum of 2 quarters · filed 2026-08-06 | $908.00K 10-Q · filed 2025-11-13 | $1.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.45M 10-Q · filed 2026-08-06 | -$1.85M derived: sum of 3 quarters · filed 2026-08-06 | -$2.15M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.09M 10-Q · filed 2026-05-07 | -$495.00K derived: sum of 2 quarters · filed 2026-05-07 | -$792.00K derived: sum of 3 quarters · filed 2026-05-07 | $49.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $595.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $298.00K derived: sum of 2 quarters · filed 2026-03-05 | $1.14M derived: sum of 3 quarters · filed 2026-03-05 | -$186.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | -$297.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $544.00K derived: sum of 2 quarters · filed 2025-11-13 | -$781.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $841.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$484.00K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$1.32M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $956.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |